2026 Speakers
Jeremy Abbate
Scientific American
Karen Akinsanya
Schrödinger
Andrew Altschuler
GOA Therapeutics
Robert Arch
Immunophotonics, Inc.
Laurent Audoly
PriveBio, Inc.
Tara Austraat-Churik
Blue Matter
Jay Campbell
Advisory Board Member
Yves Dudal
Perseo pharma AG
Cartier Esham
Esham Strategies, LLC
Alexander Gebauer
Galimedix Therapeutics, Inc
Grant Gephardt
Thermo Fisher
Christopher Ghadban
The Venture Collective (TVC)
Walter Greenleaf
Stanford University Virtual Human Interaction Lab
Guido Gualdoni
Epitome Therapeutics FlexCo
Ignacio Guerrero-Ros
Russo Partners
Paul Hastings
Nkarta
Beth Hoffman
Origami Therapeutics, Inc.
Nouhad Husseini
Regeneron Pharmaceuticals
Anna Kazanchyan
Saghmos Therapeutics
Hans Keirstead
Immunis, Inc.
Themasap Khan
Luma Group
Michael King Jr.
Rodman & Renshaw
Akhila Kosaraju
Phare Bio
William J Kridel Jr
Ferghana Partners Group
Philippe Lopes-Fernandes
Ipsen
Ons M’Saad
panluminate Inc.
Simon Mifsud
Garland Surgical Ltd
Kyle Mikson
Canaccord Genuity
Courtney Miller
Myosin Therapeutics
Ingrid Müller
Evotec
Jamie Oliver
Starton Therapeutics
Kwanyoung Park
WHITE TIGER GROUND
Dennis Purcell
Aisling Capital
John Reed
Johnson & Johnson
MaryAnne Rizk
Rizk Management Advisors
Beth Rogozinski
Oncoustics
Kat Schmolly
zebraMD
David Schull
Russo Partners
William Soliman
Accreditation Council for Medical Affairs (ACMA)
Graig Suvannavejh
Mizuho Securities USA LLC
Alanna Temme
Midsized Biotech Alliance of America (MBAA)
Edward Tenthoff
Piper Sandler
Dori Thomas-Karyat
Synthis Therapeutics, Inc
Priscilla VanderVeer
No Patient Left Behind (NPLB)
Brent Vaughan
Eratos Therapeutics, Inc.
Justin Walsh
JonesTrading Institutional Services, LLC
Michael Webb
Epion Therapeutics, Inc.
Dede Willis
Orbit Genomics, Inc.
Blake Wilson
Hogan Lovells Cadwalader
Susan Winckler
Reagan-Udall Foundation
